Related scientific articles (all)

Targeted therapies in breast cancer: are heart and vessels also being targeted?

Authors : Criscitiello C, Metzger-Filho O, Saini KS, de Castro G, Diaz M, La Gerche A, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : Breast Cancer Res
Volume : 14(3)
Pages : 209

Exploitation de la spectrométrie de masse en microbiologie : une révolution.

Authors : Martiny D, Vandenberg O
Year : 2012
Journal : J immbio
Volume : 27(4)
Pages : 177-84

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Authors : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Year : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Authors : Anghel SI, Correa-Rocha R, Correa-Rochal R, Budinska E, Boligan KF, Boliganl KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem G, Fisher DE, Lévy F, Delorenzi M, Piguet V
Year : 2012
Journal : Pigment Cell Melanoma Res
Volume : 25(4)
Pages : 482-7

Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.

Authors : Herraiz C, Journe F, Ghanem G, Jiménez-Cervantes C, García-Borrón JC
Year : 2012
Journal : Int. J. Biochem. Cell Biol.
Volume : 44(12)
Pages : 2244-2252

Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancer.

Authors : Zardavas D, Bozovic-Spasojevic I, de Azambuja E
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 612-22

Causes of death and incidence of life-support techniques limitations oncological patients dying in the ICU : a retrospective study.

Authors : Meert AP, Dept S, Berghmans T, Sculier JP
Year : 2012
Journal : Journal of Palliative Care & Medicine
Volume : 2-3
Pages : 4 pages

Survey concerning exposure of staff to UV radiation at four Brussels hospitals.

Authors : Lam Hoai XL, André J, Del Marmol V, Ghanem G, Sales F, Vereecken P
Year : 2012
Journal : Ann Dermatol Venereol
Volume : 139(2)
Pages : 91-102

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.

Authors : Maréchal R, Vos B, Polus M, Delaunoit T, Peeters M, Demetter P, Hendlisz A, Demols A, Franchimont D, Verset G, Van Houtte P, Van de Stadt J, Van Laethem JL
Year : 2012
Journal : Ann Oncol
Volume : 23(6)
Pages : 1525-30

Atteintes orbitaires secondaires des cancers systémiques et régionaux. In: Louryan S, Lemort M, éd. Imagerie de l’œil et des voies visuelles. Montpellier, France. Sauramps Médical, 2012 (978284023832

Authors : Emonts P
Year : 2012
Journal : Book
Volume : -
Pages : 87-93

Complications of mesh repair in hiatal surgery: about 3 cases and review of the literature.

Authors : De Moor V, Zalcman M, Delhaye M, El Nakadi I
Year : 2012
Journal : Surg Laparosc Endosc Percutan Tech
Volume : 22(4)
Pages : e222-5

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.

Authors : Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A, Gidron Y
Year : 2012
Journal : Auton Neurosci
Volume : 166(1-2)
Pages : 96-9

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.

Authors : Cuccuini W, Briere J, Mounier N, Voelker HU, Rosenwald A, Sundstrom C, Cogliatti S, Hirchaud E, Ysebaert L, Bron D, Soulier J, Gaulard P, Houlgatte R, Gisselbrecht C, Thieblemont C
Year : 2012
Journal : Blood
Volume : 119(20)
Pages : 4619-24

Targeted therapies in non-small cell lung cancer: which implication in routine practice.

Authors : Meert AP, Berghmans T
Year : 2012
Journal : Thoracic Surgery Bulletin of Turkish Thoracic Society
Volume : -
Pages : 167-172

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Authors : Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F
Year : 2012
Journal : Ann Oncol
Volume : 23 Suppl 7
Pages : vii155-66

Minimal residual disease and circulating tumor cells in breast cancer: open questions for research.

Authors : Ignatiadis M, Sotiriou C, Pantel K
Year : 2012
Journal : Recent Results Cancer Res.
Volume : 195
Pages : 3-9

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.

Authors : Van Laethem JL, Verslype C, Iovanna JL, Michl P, Conroy T, Louvet C, Hammel P, Mitry E, Ducreux M, Maraculla T, Uhl W, Van Tienhoven G, Bachet JB, Maréchal R, Hendlisz A, Bali M, Demetter P, Ulrich F, Aust D, Luttges J, Peeters M, Mauer M, Roth A, Neoptolemos JP, Lutz M
Year : 2012
Journal : Ann Oncol
Volume : 23(3)
Pages : 570-6

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Authors : Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Tissue Eng Part A
Volume : 18(13-14)
Pages : 1410-8

Atypical presentation and localization of granulosa cell tumor-A case report and review of the literature

Authors : Sakkas GE, Bucella D, de Wind A, Stanciu C
Year : 2012
Journal : Open Journal of Obstetrics and Gynecology
Volume : 2(2)
Pages : 161-163

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412